Hiring

Scientist I - Epigenetic Editing Technologies

Full-time · CA, United States

Job description

OPPORTUNITY Mammoth is hiring a Scientist I to contribute to R&D projects within the Editing Technologies team. The Editing Technologies team develops next-generation CRISPR tools for therapeutic genome editing applications, with scope spanning from technological ideation to translational proof-of-concept. The successful candidate will work as an individual contributor in designing novel epigenetic editing tools and evaluating their performance in mammalian cells.  Strength in wet lab execution and experimental design along with deep scientific understanding of epigenetics and epigenetic editing will be critical to the role. The candidate will work within a core team of epigenetic tool developers and collaborate cross-functionally with a diverse technical staff with expertise in disease biology, bioinformatics, protein engineering, high-throughput screening/automation, reagent production, and in vivo evaluation. This is a fantastic opportunity to impact human health by making CRISPR tools that cure genetic disease.

KEY RESPONSIBILITIES

  • Contribute creatively to the design of new epigenetic editing tools through ideation and literature review
  • Contribute to the development of scalable assays for measuring gene expression, epigenetic state, and/or cellular phenotype.
  • Plan, design and execute experiments for CRISPR tool evaluation
  • Document experiments in electronic laboratory notebooks and present results at internal meetings
  • Disclose inventions to the IP team for patenting
  • Other duties as assigned

REQUIRED QUALIFICATIONS

  • PhD in Molecular Biology, Biochemistry, Biomolecular Engineering or a related discipline. For non-PhD candidates with a Bachelor's degree, a minimum of 5 years of professional experience is required
  • 2+ years of hands-on experience designing and refining fusion proteins for CRISPR or other DNA binding proteins (ZNF, TALE)
  • 2+ years of hands-on experience designing, executing, and analyzing CRISPRa/i or epigenetic editing experiments in mammalian cells
  • 1+ years hands-on experience in at least two of the following areas:
  • Epigenetic characterization assays including bisulfite sequencing (targeted or whole genome), EM-seq, ChIP-qPCR, and/or ChIP-seq
  • Flow cytometry and/or fluorescence-activated cell sorting (FACS)
  • Transcript/protein quantification assays including RT-qPCR; d/ddPCR, RNA-seq, ELISA, and/or MSD
  • Automated methods for high-throughput molecular/cell biology workflows

PREFERRED QUALIFICATIONS

  • 1+ years experience with mammalian cell line engineering
  • 1+ years experience with developing pooled screening approaches for high-throughput tool evaluation
  • 1+ years experience working with disease-specific cell models and optimizing nucleic acid delivery via lipofection, nucleofection, and/or viral transduction
  • Working proficiency with common bioinformatics tools (Benchling, JMP, SQL, R, Python)

BENEFITS

  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Org chart

No direct reports

Teams

This job is not in any teams


Offices

This job is not in any offices


Mammoth Biosciences

3 followers

Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.


Industries

Employees

51-200

Links